Chevy Chase Trust’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
AIM
NAMA
Chevy Chase Trust's EDIT Position: Q4 2021 in Review
Chevy Chase Trust sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 7,235 shares — an estimated $298K sold.
Chevy Chase Trust first reported a position in EDIT in Q1 2018 and held it in 15 quarters. The position peaked at $83.8M in Q4 2020. 306 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.
- Chevy Chase Trust reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
- Chevy Chase Trust sold 7,235 Editas Medicine shares in Q4 2021, an estimated $298K.
- Chevy Chase Trust first reported a position in Editas Medicine in Q1 2018 and held it in 15 quarters.
- Chevy Chase Trust's Editas Medicine position peaked at $83.8M in Q4 2020.
- 306 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.
Based on Chevy Chase Trust's 13F filing for Q4 2021, filed 31 Jan 2022.